Purchase Order N0025922P0077
Award Date 1/7/22
Potential Completion Date 4/14/22
Potential Value $240K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company that produces molecular diagnostic testing systems and assays. The contract is for the delivery of APTIMA SARS-CoV-2 tests to detect COVID-19, with a potential value of $745,185.00 and a completion date of March 31, 2023. The contract is part of the agency's efforts to procure necessary medical supplies related to the Coronavirus COVID-19 national interest...
- This is a $249,560.00 firm fixed-price purchase order contract awarded by the Defense Health Agency to Gen-Probe Incorporated for the APTIMA SARS-COV-2 ASSAY. The contract has a completion date of May 12, 2022 and was awarded on February 11, 2022. Gen-Probe is a medical diagnostics company that specializes in molecular diagnostic testing systems, assays, and related products and services for the U.S. federal government. The company has held numerous contracts with defense and civilian agencies...
- This is a firm fixed-price delivery order awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the APTIMA SARS-CoV-2 ASSAY, a 250-test COVID-19 test kit. The contract has an ultimate completion date of February 18, 2022 and a ceiling value of $320,542.72. The contract is not set-aside. Gen-Probe has held numerous federal contracts with defense and civilian agencies, primarily supplying testing kits, reagents, and equipment for infectious disease...
- This is a $319,600 firm-fixed-price delivery order awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company, for COVID-19 testing reagents and the APTIMA SARS-CoV-2 assay. The award does not have a set-aside designation. Gen-Probe has held numerous federal contracts, primarily supplying testing kits, reagents, and equipment for detecting infectious diseases to defense and civilian agencies. This delivery order is part of a larger $15 million...
- This federal contract award to Gen-Probe Incorporated, a medical diagnostics company, was issued by the Defense Health Agency. The $552,691.20 firm fixed-price delivery order is for the APTIMA SARS-CoV-2 ASSAY, a COVID-19 testing kit under the Emergency Use Authorization (EUA). The contract has no set-aside designation and is scheduled for completion by September 30, 2022. Gen-Probe Incorporated holds several Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with...
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Gen-Probe Incorporated, a medical diagnostics company, for the provision of SARS COVID-19 test kits. The contract has a potential value of $317,100.00 and a completion date of June 18, 2020. The contract is not designated as a set-aside. Gen-Probe Incorporated has previously provided various medical diagnostic products and services to federal agencies, including the Defense Health...
- The Defense Health Agency awarded a $745,185 firm fixed price purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. for 94 Aptima SARS-CoV-2 assay boxes containing 250 tests per box, 47 Aptima SARS-CoV-2 control boxes with five positive and five negative controls per box, and 235 Fusion specimen lysis tubes in 100 bags per box. The place of performance is in Marlborough, Massachusetts and the period of performance runs from February 17, 2022 through September 30, 2023....
- <p>The Defense Health Agency (DOD) awarded a $745,185 purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for APTIMA SARS-COV-2 ASSAY KITS. The firm fixed price contract will provide coronavirus COVID-19 testing kits to support national interest actions in Japan, with performance taking place from May 10, 2022 through June 1, 2022.</p>
- This federal contract award is for COVID-19 REAGENTS and the APTIMA SARS-COV-2 ASSAY, awarded to Gen-Probe Incorporated, a medical diagnostics company that specializes in molecular diagnostic testing systems, assays, and related products and services for the U.S. federal government. The $127,590.00 Firm Fixed Price contract was issued by the Defense Health Agency, a defense agency, on September 10, 2020, with a completion date of September 30, 2020. The contract was not set aside and is part...
- The Defense Health Agency (DOD) awarded a $339,005 purchase order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division to provide COVID-19 test kits and supplies. The place of performance is Bethesda, Maryland and the contract period is from January 28, 2022 to February 10, 2022. The pricing structure is firm fixed price. Gen-Probe Incorporated will supply coronavirus disease 2019 test kits and related materials to the Defense Health Agency to support continued testing...